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more than three mutations of conserved PER2 residues impaired not only binding to CRY1 but also subsequent
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Circadian rhythm is an intrinsic periodicity of approximately 24 h
that is found in organisms from bacteria to mammals. Circadian
rhythms are obvious in many biological processes including physiol-
ogy and behaviour and they are controlled by an autonomous
circadian clock that is synchronised with an environmental light–
dark cycle [1]. Circadian clocks ubiquitously function in mammals
from the central nervous system to peripheral organs and they
constitute a hierarchical structure in which the master clock residing
in the suprachiasmatic nucleus [2–4] synchronises peripheral clocks
that reside in various organs [5–9].
Circadian rhythms at the cellular level are under genetic control
and they are generated mainly by CLOCK, BMAL1, PERIOD (PER), and
CRYPTOCHROME (CRY) in mammals. These components comprise an
intermolecular self-sustaining feedback-loop, which is thought to be
the entity of the molecular clock [10]. Both CLOCK and BMAL1 are
transcription factors [11], which form complexes and transactivate
many genes including Pers and Crys that contain an E-box in their
promoter regions. Translated PER1/2/3 and CRY1/2 consist of a
cytoplasmic heterodimer that enters the nucleus [12] and then
suppresses CLOCK–BMAL1-dependent transcription [10,13]. Thus
PER1/2/3 are essential negative regulators of the mammalian
circadian clock.Considerable evidence indicates a relationship between abnormal
circadian rhythmicity and PER2 mutations from cellular to individual
activity levels. The locomotor activity rhythms of mice harbouring
functionally mutated PER2 (mPER2Brdm1) gradually become dis-
rupted under constant darkness [14]. A single mutation in the
human Per2 gene (residue 662; serine substituted with glycine)
causes familial advanced sleep phase syndromes because the
mutation disrupts phosphorylation of the protein [15]. Mouse
ﬁbroblast cells with a Per2 mutation are also arrhythmic [16]. These
data indicate thatmammalian PER2 plays prominent roles in circadian
clock function.
Various studies have investigated the functional motifs and
structural domains of PER2 with unique functions that account for the
observed functional elements of PER2. The N terminal region contains a
PAS (PER, ARNT, SIM) domain comprising PAS A and PAS B domains,
which functions in dimerisation or interaction with other proteins
[17,18]. For example, glycogen synthase kinase3beta (GSK-3β) interacts
with PER2 at the PAS A and PAS B regions and regulates PER2
phosphorylation [18]. The middle region of PER2 harbours sites for
interactionwith casein kinase δ or ε that also regulates phosphorylation,
and phosphorylation partly determines period length via the stability of
this protein [15,19–21]. On the other hand, several important clock
functional proteins such as CRYs interact at the C-terminal region [22].
Interaction with CRY is one step that is essential for the molecular
feedback loop. We reported that residues 1159–1257 of rat PER2
comprise the domain for interaction with CRY1 [22]. However the
precise contribution of this protein to such interaction has not yet been
determined. Here we describe that 20 amino acids (residues 1179–
1198) of rPER2 interact with CRY1 and that conserved residues among
them play critically important roles.
Fig. 1. Residues 1159–1208 of rPER2 are necessary for interaction with mCRY1.
(a) Diagrammatic representation of constructs used for co-immunoprecipitation with
mCRY1. Internal deletion portions are represented as dotted line. (b) Lysates from COS-1
cells coexpressing mCRY1 and truncated mutants shown in (a) were immunoprecipitated
with anti-mCRY1 antibody and blotted with anti-FLAG antibody. The construct rPER2
1–171 has been described [18] and it was applied as negative control to demonstrate
absence of interaction with mCRY1. Results were reproducible in triplicate experiments.
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2.1. Plasmid construction for overexpression
The expression plasmids encoding full length of rPer2 (GenBank
Accession no., AB016532) and mouse Cry1 (GenBank Accession no.,
NM_007715) are described elsewhere [22,23]. The FLAG-tagged rPer2
expression vector was generated as follows. The coding region of
full length of rPer2 was excised from the pCXN2-rPer2 expression
plasmid [22] and divided into 4 fragments. The Not I and Xba I
restriction enzyme sites were added to the most N- and C-ﬂanking
regions respectively using PCR ampliﬁcation and then the 4
fragments were ligated into the pFLAG-CMV2 vector. The forward
and reverse ampliﬁcation primers were as follows: N-ﬂanking region,
[5′GCGGCCGCGAATGGATATGTGGACTTTTCC3′] and [5′CACTGA-
CACGGCAFAAAAAAGATTTCTCCT3′], respectively; C-ﬂanking region,
[5′GTCAAGACTCGAGACTCTTCTGAGAGCACA3′] and [5′TCTAGAT-
TACGTCTGGGCCTCCTTCCTAGG3′], respectively.
Deletion mutants were constructed by PCR ampliﬁcation and
ligated into the pFLAG-CMV2 expression vector [22]. Alanine-
substituted mutants of rPER2 1159–1257 were generated using
QuikChange® Site-Directed Mutagenesis Kits (Stratagene) according
to the manufacturer's instructions. Sequences of the mutants were
analysed to conﬁrm accuracy.
2.2. Cell culture
COS-1 cells were incubated in Dulbecco'smodiﬁed Eagle's medium
(Wako, Osaka, JAPAN) supplemented with 10% bovine foetal serum
(Biological Industries) and 100 U/mL of penicillin and 0.1 mg/mL
streptomycin (Sigma) under a 5% CO2 atmosphere at 37 °C.
2.3. Co-immunoprecipitation
Co-immunoprecipitation proceeded as described [22]. Brieﬂy,
2.5×105 COS-1 cells/well were cultured in 6-well dishes, incubated
overnight and co-transfected using Lipofectamine and Plus reagents
(Invitrogen) according to the manufacturer's instructions. The cells
were incubated overnight again, disrupted with 0.5 mL of lysis buffer
[150 mM NaCl, 0.5% NP-40, and 50 mM Tris–HCl (pH 7.5)] containing
protease inhibitor cocktail tablets (Complete; Roche) on ice for
30 min and then the lysates were clariﬁed by centrifugation for
10 min at 20,000 ×g.
To generate complexes of resin and anti-mCRY1 antibody, protein
A/G agarose beads (Santa Cruz Biotechnology) were incubated with
anti-mCRY1 anti-serum [23] for 1 h at 4 °C. The complexes were
rinsed twice with PBS and resuspended in lysis buffer.
Clariﬁed cell lysates were mixed with 20 µL of anti-FLAG or anti-
V5-conjugated resin suspension (Sigma) or with complexes of anti-
mCRY1 antibody and protein A/G agarose and rotated at 4 °C
overnight. The resin precipitated by centrifugation at 20,000 ×g for
1 min at 4 °C was resolved by sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS-PAGE).
2.4. Immunocytochemistry
Immunocytochemical analysis proceeded as described [22] with
somemodiﬁcations. Brieﬂy, COS-1 cellswere culturedonglass coverslips
in 12-well plates (1.5×105 cells/well) for 24 h and transfected using
Fugene 6 (Roche) according to themanufacturer's instructions. The cells
were rinsed once with PBS, ﬁxed using 4% paraformaldehyde in PBS for
30 min, and thenpermeabilisedusing0.05%Oxtoxynol-9 (namely Triton
X-100, Sigma) inPBS for 15 min. After twowasheswithPBS, non-speciﬁc
bindingwas blockedby incubationwith 5% bovine serumalbumin (BSA)
(Sigma) in PBS for 30 min at room temperature. Anti-mCRY1anti-serum
[23], anti-rPER2 anti-serum [22], anti-FLAGM2antibody (Sigma)and/oranti-V5 antibody (Invitrogen) were diluted in 5% BSA and incubated
with the cells for 2 h at room temperature. The cells were washed three
times with PBS and incubated with ﬂuorescence-labelled Alexa 488 and
Alexa 568 secondary antibodies (Invitrogen) and with 4′,6′-diamidino-
2-phenylindole (DAPI) in 5% BSA solution for 1 h. Thereafter, the
coverslips were rinsed three times with PBS and once with distilled
water and then embedded with MOWIOL® (polyvinyl alcohol resin).
Over 50 cells were counted under light microscopy to determine the
subcellular localization of PER and CRY.
2.5. Luciferase assays
The mouse arginine vasopressin (AVP)-Luc reporter plasmid has
been described elsewhere [24]. COS-1 cells (8×104/well) were
cultured in 24-well dishes and transfected using Lipofectamine and
Plus reagents according to the manufacturer's instructions. After
incubation for 48 h, the cells were then lysed and analysed using the
luminescent Dual-Luciferase® Reporter Assay System (Promega) as
described by the manufacturer.
2.6. Statistical analysis
The statistical signiﬁcance of differences among groups was
analysed by Student's t-test. A 1% level of probability was considered
signiﬁcant.
3. Results
3.1. C-terminal amino acid residues (1179–1198) of PER2 are necessary
for binding to CRY1
Wepreviously reported that theC-terminal regionof rPER2 (residues
1157–1257) interacts with human CRY 1 [22]. Here, we narrowed the
number of interactive residues in the region down to 20.We divided the
segment (residues 1159–1257) into two and determined which
segment contained the residues necessary for interaction with CRY1.
Because short fragments of 50 residues were undetectable in the COS-1
cells (data are not shown), two FLAG-tagged deletionmutants (residues
1059–1208 and residues 1059–1257 lacking 1159–1208, named δ1159–
1208)were prepared [Fig. 1(a)] and co-immunoprecipitatedwith CRY1.
Fig. 3. Sequence alignment of C-terminal regions of rPER2 with mPER2, hPER2 and
rPER1 using COBALT programme [25]. Asterisks indicate conserved residues among
these four proteins. Underlined residues indicate substituent positions for simulta-
neous substitutions in Figs. 5, 6 and 7. Area surrounded by dotted lines indicates mCRY1
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whereas δ1159–1208 did not.
To further deﬁne the region, we generated 8 FLAG-tagged fragments
comprising residues 1059–1198 (A), 1059–1188 (B), 1059–1178
(C), 1059–1168 (D), and residues 1059–1257 without 1159–1168
(δ1159–1168, E), 1159–1178 (δ1159–1178, F), 1159–1188 (δ1159–
1188, G) and 1159–1198 (δ1159–1108, H) [Fig. 2(a)]. These mutants
weredesigned to cut residues 1159–1208 into groupsof 10 residues, and
sets (A) and (H), (B) and (G), (C) and (F), and (D) and (E) contained
residues complementary to 1159–1208. Fig. 2(b) shows that fragments
(A), (E), and (F) interactedwith CRY1,whereas the others did not. These
results indicated that residues 1179–1198 are required for interaction
with CRY1.binding residues 1179–1198 of rPER2 and corresponding residues of the other three
proteins.3.2. Single substitution of conserved residues in C-terminus of rPER2 did
not abolish interaction with CRY1
We postulated that the residues responsible for interaction are
conserved among species or isoforms and thus used the COBALT
programme to compare the amino acid sequences of rPER2 (NCBI
Reference Sequence NP_113866) 1179–1198 with those of mPER2
(NP_035196), hPER2 (NP_073728) and rPER1 (NP_001029297) to
screen common residues in the C-terminus [25]. Here, rPER1 was
included in this alignment because mPER1 C-terminal region binds to
CRY1 is also demonstrated [26]. On the other hand, to the best of our
knowledge, these binding tests have not yet been demonstrated onFig. 2. Residues 1179–1198 of rPER2 are necessary for interaction with mCRY1.
(a) Diagrammatic representation of constructs used for co-immunoprecipitation with
mCRY1. Internal deleted portions are represented as dotted line. Shaded areas
are portions of residues 1159–1208. (b) Total lysates from COS-1 cells coexpressing
V5-tagged mCRY1 and FLAG-tagged truncated mutants shown in (a) were immunopre-
cipitated with anti-FLAG antibody and blotted with anti-FLAG antibodies and anti-V5
antibodies. 1059–1208 and δ1159–1208 served as positive and negative controls,
respectively. Only Fragments (A), (E) and (F) interacted with mCRY1.PER3. Fig. 3 shows that residues 1179, 1181, 1183, 1185, 1188, 1189,
1192, 1193 and 1195 are conserved among these PER proteins. We
then individually substituted these conserved residues with alanine
and examined interaction with CRY1. Fig. 4 shows that all of these
mutated fragments interacted with CRY1.
3.3. Multiple mutations of conserved residues in C-terminus of rPER2
affected interaction with CRY1
To evaluate the impact of the conserved residues upon interaction
with CRY1, we selected 5 (residues 1179, 1181, 1188, 1189 and 1195)
of 9 conserved residues mentioned above and multiply substituted
several of themwith alanine as follows: residues 1179, 81 (I) and 1188,
89 (J) (two-residue substitution); residues 1179, 81, 95 (K) and
1181, 88, 95 (L) (3-residue substitution); residues 1179, 81, 88, 89 (M)
(4-residue substitution); residues 1179, 81, 88, 89, 95 (N) (5-residue
substitution) [Fig. 5 (a)]. Fig. 5 (b), shows thatmutantswithmore than
a 3-residue substitution [(K), (L), (M), and (N)] did not interact with
CRY1. On the other hand, interactions of (I) and (J) with CRY1 were
obscure [Fig. 5(b) and Supplementary Figure]. These data indicate that
multiple substitutions of conserved residues among species or
isoforms weaken interactions with CRY1.
3.4. Multiple mutations of conserved residues in C-terminus of rPER2
change the subcellular localisation of PER2
The present results indicated that these mutations may alter the
subcellular localisation of PER2. We thus constructed full-length
FLAG-tagged rPER2 plasmids containing multiple substitutions to
conﬁrm this notion. The substituted positions are referred to as (I), (J),
(K), (L) and (N) and the corresponding mutants of full-length FLAG-
tagged rPER2 are named (I′), (J′), (K′), (L′) and (N′) respectively. WeFig. 4. No single substitution of conserved residues of rPER2 1179–1198 affects
interaction with mCRY1. Total lysates from COS-1 cells coexpressing mCRY1 and single
substitution mutants of rPER2 1159–1257 were immunoprecipitated with anti-FLAG
antibody and blotted with anti-FLAG antibodies and anti-V5 antibodies. Substituted
residues are indicated at top of each lane. Positive and negative controls were 1159–
1257 and δ1159–1208, respectively. All single substitution mutants interacted with
mCRY1.
Fig. 5. Simultaneous substitutions of conserved residues of rPER2 1179–1198weakened
interaction with mCRY1. (a) Amino acid sequences 1179–1198 of intact rPER2 and
mutants are shown. Dashed lines in mutant sequences indicate residues in common
with those of intact rPER2. Substituted residues are indicated as A. (b) Total lysates from
COS-1 cells coexpressing mCRY1 and single substitution mutants of rPER2 1159–1257
were immunoprecipitated with anti-FLAG antibody and blotted with anti-FLAG
antibodies and anti-V5 antibodies. Fragments are indicated at top of each lane. Positive
and negative controls were 1159–1257 and δ1159–1208, respectively. Mutants are
indicated at top of each lane. Asterisks indicate mutants of which results of co-
immunoprecipitation with mCRY1 were not reproducible. Further results are shown in
Supplemental Figure.
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tagged rPER2 containing multiple substitution of residues 1180, 82,
84; 1186, 87, 94; 1194, 96, 97 [referred to as (O′), (P′) and (Q′),
respectively]. These residues are not conserved among species or PER
isoforms (Fig. 3) and we postulated that they do not play signiﬁcant
roles in interaction with CRY1. Fig. 6 shows typical subcellular
localisation of rPER2 or its mutants co-expressed with CRY1 in COS-1
cells. When expressed intact rPER2 with CRY1, PER2 and CRY1 were
localised in the nuclei of 83.6% and 95.1% of transfected cells. These
results were compatible with previous ﬁndings [22]. When (N′) was
expressed with CRY1, the mutant was localised in the cytoplasm and
nucleocytoplasm of 77.9% and 19.1% of transfected cells, respectively,
whereas CRY1was localised in the nuclei of 95.6% of these cells. When
(K′) or (L′) was expressed with CRY1, these PER 2 mutants tended to
localise in a manner similar to that of (N′), whereas 20.0%, 42.0% and
38.0% of the cells transfected with (I′) displayed cytoplasmic,
nucleocytoplasmic and nuclear localization, respectively. The results
were similar for (J′), with 24.5%, 41.5% and 34.0% of the transfected
cells, respectively, being similarly localised. On the other hand, the
subcellular localization of (O′), (P′) and (Q′) tended to differ from that
of (K′) or (L′). The localisation of (O′) in transfected cells was 22.1%,
75.6% and 2.3% nucleocytoplasmic, nuclear and cytoplasmic, respec-
tively, that of (P′) was 17.5%, 75.0% and 7.5%, respectively and that of
(Q′) was 15.6%, 80.5% and 3.9%, respectively. Even though these
mutants harboured 3 substitutions per protein, their subcellular
localisation was similar to that of intact rPER2.
3.5. Effect of multiple mutations of conserved C-terminal residues on
CLOCK–BMAL1
Because of the altered subcellular localization of rPER2 caused by
multiple substitutions, we postulated that the function of rPER2 also
changes in the presence of mutations. To evaluate functional changes
in the PER2 mutants, we performed luciferase assays using the AVPpromoter region. Fig. 7 shows that the ratio of luminescence intensity
was 308-fold greater in lysates of COS-1 cells in which CLOCK and
BMAL1 expression vectors (0.2 µg) were co-transfected with the
reporter plasmid, than in lysates of cells that were not transfected
with these vectors. When the CRY1 vector (0.02 µg) was transfected
with CLOCK and BMAL1, the luminescence ratio was 40.4% of that of
the cells transfected with CLOCK and BMAL1 expression vectors
(0.2 µg). We then added 0.02, 0.06 and 0.2 µg of Per2 or (N′) to the
sets of CLOCK, BMAL1 and CRY1 and determined relative lumines-
cence intensities. The respective ratios compared with cells trans-
fected with CLOCK and BMAL1 were as follows: PER2, 28.0, 16.7 and
9.53%; (N′), 31.0, 25.2 and 13.2%. At concentrations of 0.06, 0.2 µg,
PER2 and (N′) signiﬁcantly differed (p<0.01).
4. Discussion
The cytoplasmic heterodimer of PER and CRY enters the nucleus
where it suppresses CLOCK–BMAL1 transactivation. The formation of
PER and CRY complexes is considered an important step in generation
of the molecular feedback loop of the circadian clock. As the results
shown in Fig. 2, we concluded that residues 1179–1198 of rPER2 are
indispensable for interaction with CRY1. However, we did not
investigate whether these constructs bind to CRY1 with equal afﬁnity.
We cannot exclude putative other supportive contribution of the
deleted residues (such as residues 1199–1208) for binding to CRY1. To
evaluate the afﬁnities of these fragments for mCRY1, other methods
such as surface plasmon resonances are required. We also discovered
that a single substitution of only one conserved amino acid residue to
alanine is not sufﬁcient to disrupt the interaction. However,
accumulating alanine substitutions within these residues impaired
not only interaction with CRY1 but also the nuclear translocation of
PER2. Moreover, accumulating substitutions of non-conserved resi-
dues did not affect interaction with CRY1. These results indicate that
the amino acid residues conserved in the C-terminus of PER2 seem
to play important roles for both binding to CRY1 and subsequent
nuclear translocation. On the other hand, we could not specify a single
C-terminal residue in rPER2 that is critical for binding to CRY1 using
alanine substitution method. However, we would not exclude the
possibility that single critical residue could be identiﬁed if we apply
more drastic mutations, such as substituting hydrophobic residues to
hydrophilic ones.
Several models can be proposed based on our ﬁndings to interpret
the mechanisms of CRY1–PER2 interaction. (1) The conserved
residues of 1179–1198 are mutually responsible for the structural
integrity of the CRY binding domain in the C-terminus of PER2. When
several of these residues are substituted, the structural integrity of
C-terminus is not sufﬁciently maintained, which prevents binding.
(2) These residues are located at the interface of the CRY binding
domain of PER2. Although no individual conserved residue plays a
leading role in interaction, multiple substitutions might have an
additive effect. When such an additive effect reaches a putative
threshold, interaction no longer occurs. (3) Residues 1179–1198
constitute a natively unfolded region that assumes a functional
structure only when PER2 forms a complex with CRY1. Multiple
substitutions of these conserved residues may affect compositely for
comprising activated structure for complex formation. Structural
information should help clarify which of these models is reliable.
Other reports have shown the crystal structure of PAS repeat in
Drosophila PERIOD and that in mouse PER2, and interaction
mechanisms between these PAS domains and other proteins that
also contain PAS domains have been unveiled [17,27]. However, the
C-terminal residues of PER proteins have unique sequences and the
blastp programme with default parameters in NCBI did not identify a
protein with a conserved domain and no structural information is
presently available. Alternatively, we used bioinformatic methods to
estimate the structure of the C-terminal residues of rPER2 1159–1257
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procedure). We initially estimated the natively unfolded region using
the DISOPRED 2 programme [28] and found that residues 1159–1232
were located in the ordered region whereas the others were in the
disordered region. These results indicate that residues 1159–1232Fig. 6. Subcellular localisation of rPER2 or substitution mutants with mCRY1. (a) Full length F
co-expressed with V5-tagged mCRY1. Transfected cells were triple-stained with anti-V5
recombinant mCRY1 and DAPI stained the nucleus. (b) Quantitative analysis of results show
“nucleocytoplasm”. To determine ratios of cells with predominant localisation to total tranconstitute a speciﬁc structure. The secondary structure was also
predicted in the Jpred 3 server [29] and the result indicates that the
residues 1183–1197 constitute the second helix. We then estimated
the tertiary structure of the C-terminus using the I-TASSER
programme [30–32]. The C-terminal amino acid sequences of rPER2LAG-tagged rPER2 or substituted mutants (I′), (J′), (K′), (L′), (N′), (O′), (P′) or (Q′) were
antibodies (red), anti-rPER2 (green) and DAPI (blue). Anti-V5 antibodies recognised
n in panel (a). Subcellular localisation was categorised as “cytoplasm”, “nucleus” and
sfected cells, >50 cells were counted per experiment under light microscopy.
Fig. 7. Inﬂuence of rPER2 or (N′) on ability of CRY1 to suppress CLOCK-Bmal1-mediated
transcription of AVP gene. Presence (+) or absence (−) of expression plasmids (CLOCK
and BMAL1, 0.2 µg; CRY1, 0.02 µg; PER2 or (N′), 0.02, 0.06 and 0.2 µg). Values are
shown as means±SD of 3 independent samples. *P<0.01 compared with values for
rPER2 and (N′).
Fig. 8. Structural predictions of rPER2 1159–1257 using I-TASSER. Five possible models
predicted by I-TASSER [30–32] were shown. The 5 substituted residues in the
experiments were coloured in red. C-scores obtained for Models 1, 2, 3, 4 and 5 of
rPER2 1159–1257 were −3.89, −4.05, −4.36, −4.39 and −4.53, respectively.
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template is available to exploit for estimations. The I-TASSER
programme is an ab-initio structural prediction algorithm that can
be invoked when a structural template is unavailable. Based upon the
I-TASSER estimation, 5 structural candidates were proposed among
which, the common structural feature of residues 1179–1198was that
most of them are located in the second helix that resides in the
internal region of the molecule (Fig. 8). The secondary structure
prediction is also available from I-TASSER server and the result was
compatible with the Jpred 3 prediction above-mentioned. The results
of these estimations suggest that the CRY1 binding region is helical
and preceded by another helical region. The structure of the CRY
binding domain might be loosened by substitutions which would
weaken the ability to interact. However, these predictions are based
on probability calculations by computational science and we cannot
exclude other interpretations. Furthermore, other methods such as a
crystallographic approach will be required for precise discussion from
the viewpoint of structural analysis.
The PER binding domain of CRY1 was also investigated and the
putative coiled coil region of CRY1 C-terminus is reported to interact
with PER1 and PER2 [33]. Considering this report and our ab-initio
prediction together, the second helix of PER2 C-terminus may pack
against the coiled coil region of CRY1.
As substitute accumulation in the conserved C-terminal residues of
PER2 impaired the nuclear translocation of PER2, we postulated that
the ability of PER2 to suppress CLOCK–BMAL1 transactivation would
also be affected. Although both PER2 and (N′) dose-dependently
suppressed interaction, the suppressive effect upon interaction
between intact PER2 with CRY1 was slightly but signiﬁcantly greater
than that upon interaction between (N′) and CRY1. Thus, these facts
indicated that the formation of PER2–CRY1 complexes and their entry
into the nucleus in not entirely, but absolutely associated with a
suppressive effect on CLOCK–BMAL1 transactivation. In addition, the
suppressive effects of overexpressed PER2 alone [34] indicate that
cytosolic PER2 has somehow suppressive mechanisms.Clock molecules interact with other proteins in variation from time
to time invivo states. For example, PER1andPER2make large complexes
with other proteins including CRY1 and CRY2 at night in mouse livers
and the abundance and sizedistributionof the complexes vary over time
[35]. Further, the modiﬁed states (acetylated [36] or phosphorelated
[18]) of the clock proteins are also different from time to time. Our
report, here focused on PER2 and CRY1 interaction, shows a partial but
essential mechanism of the complex formation of the clock proteins.
We concluded that PER2 has aminuscule (1/60 of the total length of
this protein) but robust interface that interacts with CRY1, because a
singlemutation did not abolish interactionwith CRY1. However, among
the 20 involved amino acid residues, those that are conserved seem to
play important roles in a concerted manner because multiple substitu-
tions of the conserved residues with alanine weakened the interaction.
Inaddition, thesemutations changed the subcellular localisationof PER2
and the suppressive functions of these proteins. The interactions of
mPERs and mCRY1 have already been reported elsewhere [12]. As
shown in Fig. 3, the C-terminal residues of rPER1 and rPER2 andmPER2
are highly conserved. The residues selected for our experiments are also
conserved in rPER3 and mPER3. These facts and our results imply that
these residues selected have functionally similar roles in PER1, 2 and 3
for the interaction with CRY1. These residues are certainly involved in
the molecular circadian clock mechanism.
Recently, Chen et al. elegantly demonstrated the important role of
PER2 to generate circadian rhythm in vivo and in vitro [37]. According
to them, CRY cannot inhibit the transcription activity of CLOCK–
BMAL1 complex directly and PER2 works as a scaffold between
CLOCK–BMAL1 and CRY to generate the repressive effect. Our report
here focused on detailed analysis of CRY1-interacting region of PER2
and would serve valuable information on the generation of the
circadian rhythmicity.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamcr.2010.01.012.
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